Product Program year 2025 Source: CMS Open Payments

ClosureRFS

Device EndoVenous Therapies

PDI 00643169862999

Open in the dashboard

General payments

$25,345

281 payments

Research payments

$0

0 payments

Through program year 2025, $25,345 in general payments and $0 in research payments were reported against ClosureRFS (EndoVenous Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $11,844 76
2024 General $2,554 62
2023 General $3,303 38
2022 General $5,809 49
2021 General $1,835 56

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $25,345 281 payments
Top recipients General payments · program year 2025
  1. Misaki Kiguchi Vascular Surgery · Washington, DC $4,200 35% · 1 payment
  2. Rodney Raabe Vascular & Interventional Radiology · Spokane, WA $3,150 27% · 1 payment
  3. Dean Lomago Thoracic Surgery (Cardiothoracic Vascular Surgery) · Butler, PA $728 6% · 1 payment
  4. Pratik Patel Cardiovascular Disease · Monroe, NJ $560 5% · 1 payment
  5. Christopher Molvar Vascular & Interventional Radiology · Chicago, IL $280 2% · 1 payment

The top 5 of 64 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $5,445 46% · 18 practitioners
  2. Vascular & Interventional Radiology Radiology $3,470 29% · 4 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $889 8% · 6 practitioners
  4. Cardiovascular Disease Internal Medicine $682 6% · 4 practitioners
  5. Interventional Cardiology Internal Medicine $592 5% · 4 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $4,200 35% · 1 recipient
  2. Washington $3,150 27% · 1 recipient
  3. New Jersey $840 7% · 2 recipients
  4. Pennsylvania $728 6% · 1 recipient
  5. Virginia $440 4% · 11 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

281 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record